ask="40.00"
ask_size="500"
average_daily_volume="218639"
bid="N/A"
bid_size="N/A"
book_value="3.79"
change="-1.65"
change_from_200_day_moving_average="2.74"
change_from_50_day_moving_average="0.27"
change_from_52_week_high="-4.25"
change_From_52_week_low="14.88"
change_in_percent="-5.38%"
close="29.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-3.04"
eps_estimate_next_quarter="-0.72"
eps_estimate_next_year="-2.31"
ex_dividend_date="N/A"
float_shares="15981000"
high="30.81"
high_52_weeks="33.25"
last_trade_date="3/16/2017"
last_trade_price="29.00"
last_trade_size="6396"
last_trade_time="4:00pm"
low="28.70"
low_52_weeks="14.12"
market_capitalization="621.53M"
moving_average_200_day="26.26"
moving_average_50_day="28.73"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="39.67"
open="30.81"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="+10.43%"
percent_change_from_50_day_moving_average="+0.93%"
percent_change_from_52_week_high="-12.78%"
percent_change_from_52_week_low="+105.38%"
previous_close="30.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.09"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.77"
stock_exchange="NMS"
symbol="ACRS"
volume="301536"
weeks_range_52="14.12 - 33.25"
